Heterocyclic Building Blocks-quinoxaline

50998-17-9, 6-Bromoquinoxaline is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

To a solution of 11a (108 mg, 499 mumol), 6-bromoquinoxaline (157 mg, 751 mumol), Bu4NOAc (302 mg, 1.00 mmol) and Pd(OAc)2 (17 mg, 75.7 mumol) in NMP (1 mL). The reaction mixture was stirred for 4 h at 100 oC and cooled to room temperature. The mixture was concentrated under reduced pressure, diluted with water and extracted with EtOAc (3 ¡Á 5 mL). The EtOAc solution was washed with brine (5 mL), dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The residue was purified by column chromatography (1:1 hexane/EtOAc) to afford the compound 12a (31.8 mg, 19%) as a yellow solid. TLC: Rf 0.28 (1:1 hexane/EtOAc). mp: 78.6-80.6 oC. 1H-NMR (400 MHz, CDCl3) delta 8.89 (AB quartet, 2H, J = 2.0 Hz), 8.08 (d, 1H, J = 8.0 Hz), 8.07 (s, 1H), 7.72 (t, 1H, J = 8.0 Hz), 7.63 (dd, 1H, J = 8.0 Hz, J = 2.0 Hz), 7.60 (d, 1H, J = 8.0 Hz), 7.12 (d, 1H, J = 8.0 Hz), 2.80 (t, 2H, J = 8.0 Hz), 2.19 (s, 3H), 1.74 (quintet , 2H, J = 8.0 Hz), 1.36 (sextet, 2H, J = 8.0 Hz), 0.88 (t, 3H, J = 8.0 Hz). 13C-NMR (100 MHz, CDCl3) delta 158.0, 149.1, 147.4, 145.6, 145.5, 142.6, 142.5, 138.9, 132.5, 132.0, 130.9, 130.2, 129.0, 123.3, 115.0, 31.6, 24.6, 23.6, 22.4, 13.7. HRMS (ESI) calcd. for C20H21N6 (M+H): 345.1822; found 345.1824., 50998-17-9

50998-17-9 6-Bromoquinoxaline 610939, aquinoxaline compound, is more and more widely used in various fields.

Reference£º
Article; Li, Fei; Park, Yunjeong; Hah, Jung-Mi; Ryu, Jae-Sang; Bioorganic and Medicinal Chemistry Letters; vol. 23; 4; (2013); p. 1083 – 1086;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.55686-94-7,2-Chloro-7-nitroquinoxaline,as a common compound, the synthetic route is as follows.

55686-94-7, 20 mL of triethylamine (3 eq.) and 6.8 mL ofp-methoxybenzylamine (1.05 eq.) were added to a solutionof 2-chloro-7-nitroquinoxaline (4) (10.13 g, 48 mmol) inethanol (160 mL). The reaction mixture was refluxed for3 h. The solution was evaporated and the solids were filteredand washed with water to obtain an orange colored solid(13.94 g). Yield 93%; mp 171-173 C (lit. 167-169 C);13ATR/FTIR nu / cm-1 3389, 3077, 2928, 1615, 1538, 1509,1338, 741; 1H NMR (200 MHz, DMSO-d6) delta 8.50 (t, 2H,J 6.0, NH and H3), 8.27 (d, 1H, J 2.0, H8), 8.05 (dd, 1H,J 2.0, 9.0, H6), 7.96 (d, 1H, J 8.0, H5), 7.36 (d, 2H, J 8.0,H3?), 6.91 (d, 2H, J 8.0, H4?), 4.56 (d, 2H, J 6.0, CH2),3.73 (s, 3H, OCH3). 13C NMR (50 MHz, DMSO-d6)delta 158.4, 152.8, 147.5, 143.6, 141.4, 139.3, 130.4, 129.9,129.2, 120.9, 116.8, 113.8, 55.1, 43.3; DEPT-135 (50 MHz,DMSO-d6) delta 143.6, 129.9, 129.2, 120.9, 116.8, 113.8,55.1, 43.3; ESI-MS 309.3; HPLC at 230 nm 96.7% andat 254 nm 100%.

The synthetic route of 55686-94-7 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Do Amaral, Daniel N.; De Sa Alves, Fernando R.; Barreiro, Eliezer J.; Laufer, Stefan A.; Lima, Lidia M.; Journal of the Brazilian Chemical Society; vol. 28; 10; (2017); p. 1874 – 1878;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.50998-17-9,6-Bromoquinoxaline,as a common compound, the synthetic route is as follows.

50998-17-9, Step 2: 6-(5,5-Dimcthyl-l,3,2-dioxaborinan-2-yl)quinoxalinc (E2)A mixture of 6-bromoquinoxaline (1.0 eq.), bis-(neopentylglycolato)diborane (1.1 eq.), KOAc (3.0 eq.) and Pd(dppf)Cl2 (0.05 eq.) in 1,4-dioxane was degassed with a stream of Ar for 10 minutes and then heated at 11O0C for 4 hrs. The reaction mixture was concentrated and the residue used in the next step without further purification. MS (ES) Ci3H5BN2O2 requires: 242, found: 175 (M-[C5Hi0] +H+).

As the paragraph descriping shows that 50998-17-9 is playing an increasingly important role.

Reference£º
Patent; ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA; WO2007/93827; (2007); A1;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1593-08-4,2-Formylquinoxaline,as a common compound, the synthetic route is as follows.

General procedure: A 100-mL, round-bottom flask equipped with a magnetic stirring bar was charged with TZD (1 mmole) and rhodanine(1 mmol) in ionic liquid ChCl/urea was added aldehyde (1mmol). The reaction mixture was stirred for adequate amount of time under solvent-free conditions (Table 2). The progress of the reaction was monitored by TLC(Chloroform: Methanol (4:1). After completion of the reaction, H2O (3 ml) was added and ILs separated. Then, the obtained crude compound was collected by filtration and then washed with water and methanol. Finally, products were recrystallized from ethanol to afford (1-10) a, b in the excellent yield., 1593-08-4

The synthetic route of 1593-08-4 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Akhavan, Malihe; Bekhradnia, Ahmadreza; Foroughifar, Naser; Pasdar, Hoda; Combinatorial chemistry and high throughput screening; vol. 22; 10; (2019); p. 716 – 727;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

50998-17-9, 6-Bromoquinoxaline is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Example 13A 1-Quinoxalin-6-yl-ethanone A solution of 6-bromo-quinoxaline (261 mg, 1.25 mmol), 1-ethoxyvinyltri-n-butyltin (0.47 mL, 1.4 mmol), palladium(II) acetate (16 mg) and tri-t-butylphosphonium tetrafluoroborate (41 mg) in anhydrous DMF (4 mL) under a nitrogen atmosphere was heated at 120 C. for 1 hr. The reaction mixture was cooled to ambient temperature and partitioned between ethyl acetate (25 mL) and H2O (10 mL). The organic extraction was washed with brine, dried (MgSO4), filtered, and concentrated. The concentrate was chromatographed on silica gel eluding with ethyl acetate:hexanes (1:1) to provide 110 mg of the title compound. 1H NMR (300 MHz, CDCl3) delta 2.79 (s, 3H), 8.18 (d, J=9 Hz, 1H), 8.36 (dd, J=9 Hz, J=3 Hz, 1H), 8.70 (d, J=3 Hz, 1H), 8.95 (s, 2H); MS (DCl/NH3) m/z 173 (M+H)+., 50998-17-9

50998-17-9 6-Bromoquinoxaline 610939, aquinoxaline compound, is more and more widely used in various fields.

Reference£º
Patent; Altenbach, Robert J.; Black, Lawrence A.; Chang, Sou-Jen; Cowart, Marlon D.; Faghih, Ramin; Gfesser, Gregory A.; Ku, Yi-Yin; Liu, Huaqing; Lukin, Kirill A.; Nersesian, Diana L.; Pu, Yu-ming; Curtis, Michael P.; US2005/272736; (2005); A1;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

91-19-0,With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.91-19-0,Quinoxaline,as a common compound, the synthetic route is as follows.

Step 11 -(quinoxalin-2-yl)ethanone (JS110)Quinoxaline (1 .1864 g, 9.1 1 mmol), Pyruvic acid (1.90 ml, 27.3 mmol), AgN03 (0.124 g, 0.73 mmol), N2H8S208 (3.12 g, 13.67 mmol) and H2S04 (0.49 ml, 9.1 1 mmol) were stirred in 1 :1 CH2CI2/H20 (150 ml) at 40 C for 2 ? h. The solution was then basified via the addition of NaOH and the organics extracted (3x) and washed brine, dried (MgS04), filtered and solvent removed. Flash chromatography (Pet Ether; 3:1 Pet Ether/EtOAc) afforded the title compound as a yellow solid (617.5 mg, 3.91 mmol, 42.9%). Mpt: 70-74 C [Lit.( J. Org. Chem., 1991 , 56, 2866-2869) 76-97 C]; Rf = 0.24 (3:1 Pet Ether/EtOAc); IR (vmax/cm”1, thin film): 1689 (CO stretch), 1357; 1H NMR (500 MHz, CDCI3): deltaEta = 2.84 (s, 3H, 12-H), 7.82-7.90 (m, 2H, 7,8-H), 8.14-8.21 (m, 2H, 6,9-H), 9.47 (s, 1 H, 3-H); 13C NMR (125 MHz, CDCI3): 5C = 25.6 (C-12), 129.5 (C-6), 130.5 (C-8), 130.8 (C-9), 132.3 (C-7), 141 .1 (C-10), 143.1 (C-3), 143.9 (C-5), 146.6 (C- 2), 199.8 (C-11 ); LRMS m/z (El+): 172 [M]+, 130 [M-Ac]+, 86; HRMS m/z (El+): Found 172.06372; Ci0H8N2O requires 172.0631 1 ; Anal. Calcd. for Ci0H8N2O: C, 69.76; H, 4.68; N, 16.27. Found C, 69.28; H, 4.56; N, 16.00%.

The synthetic route of 91-19-0 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; UCL BUSINESS PLC; BIRKBECK COLLEGE; WAKSMAN, Gabriel; TABOR, Alethea; SAYER, James; WALLDEN, Karin; WO2012/168733; (2012); A1;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

76982-23-5, 5-Bromoquinoxaline is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

76982-23-5, General procedure: To a magnetically stirred solution of quinoxaline (1) (2.60g, 20.0mmol) in chloroform (150mL) was added m-CPBA (13.45g, 77%, 60.0mmol) portionwise at 0C. The reaction mixture was stirred for 48hat room temperature. The mixture was diluted with a solution of sodium hydroxide (10%, 20mL) and extracted with methylene chloride (3¡Á50mL). The combined organic layers were washed with saturated brine (2¡Á30mL), water, dried over Na2SO4, and filtered. The solvent was removed in vacuo. Quinoxaline-1,4-dioxide (26),20f,28 (3.20g, 99%) was obtained as a pure product (Yellow solid, mp 241-242C, lit.20f mp 241-243C

As the paragraph descriping shows that 76982-23-5 is playing an increasingly important role.

Reference£º
Article; Ucar, Sefa; E?siz, Selcuk; Da?tan, Arif; Tetrahedron; vol. 73; 12; (2017); p. 1618 – 1632;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1204-75-7,3-Oxo-3,4-dihydroquinoxaline-2-carboxylic acid,as a common compound, the synthetic route is as follows.

The resulting compound (113 mg, 0.350 mmol) was condensed with 3-hydroxyquinoxaline-2-carboxylic acid (68.6 mg, 0.350 mmol) to afford the desired title compound (107 mg, yield 66%) as a yellow solid. 1H-NMR (DMSO-d6, 400 MHz) delta: 12.85 (1H, brs), 9.56 (1H, m), 7.87 (1H, dd, J=8.2 Hz, 7.8 Hz), 7.78 (2H, d, J=9.0 Hz), 7.65 (1H, dd, J=7.8 Hz, 7.4 Hz), 7.40 (1H, d, J=7.4 Hz), 7.38 (1H, d, J=8.2 Hz), 7.19 (2H, dd, J=9.0 Hz, 4.2 Hz), 5.00 (1H, m), 4.83 (1H, m), 4.07-3.81 (2H, m), 3.61-3.16 (2H, m), 2.14-1.46 (6H, m), 0.92 (3H, t, J=7.4 Hz). IR (KBr) cm-1: 2965, 2220, 1685, 1630, 1505, 1250. MS (ESI, m/z): 460 (M+H)+. HRMS (ESI, m/z): 460.1973 (Calcd for C25H26N5O4: 460.1984).

1204-75-7, The synthetic route of 1204-75-7 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Daiichi Sankyo Company, Limited; EP2258697; (2010); A1;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

55687-34-8,With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.55687-34-8,6-Bromoquinoxalin-2(1H)-one,as a common compound, the synthetic route is as follows.

Example 16 1-(6-Bromoquinoxalin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (38)To 6-bromoquinoxalin-2(1H)-one (250 mg, 1.11 mmol) was added POBr3 (500 mg, 2.61 mmol) at RT. The reaction mixture was gradually heated to 130 C. and stirred for 2 h. After completion of reaction (by TLC), the reaction mixture was cooled to 0 C., neutralized with satd NaHCO3 solution (50 mL) and extracted with EtOAc (2¡Á50 mL). The combined organic extracts were washed with H2O (50 mL) and brine (50 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure to obtain the crude material. Purification by silica gel column chromatography (eluting with 10% EtOAc/hexane) afforded compound AI (160 mg, 0.55 mmol, 50%) as an off-white solid. 1H NMR (200 MHz, CDCl3): delta 8.84 (s, 1H), 8.30 (d, J=9.0 Hz, 1H), 7.96-7.82 (m, 2H).

As the paragraph descriping shows that 55687-34-8 is playing an increasingly important role.

Reference£º
Patent; VIAMET PHARMACEUTICALS, INC.; US2012/329802; (2012); A1;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.6298-37-9,Quinoxalin-6-amine,as a common compound, the synthetic route is as follows.

6298-37-9, 1H-indole-6-amine (116.3 mg, 0.88 mmol), final product 03 (94.5 mg, 0.29 mmol) and triethylamine (95.4 mg, 0.94 mmol) were added to a round bottom flask, and 2 mL of DMF was dissolved.Heat to 50 C and stir overnight.At the end of the reaction, 2 mL of water was added, acidified with trifluoroacetic acid, and purified by HPLC to obtain 87.4 mg of a yellow oil

As the paragraph descriping shows that 6298-37-9 is playing an increasingly important role.

Reference£º
Patent; Chinese Academy Of Sciences Shanghai Pharmaceutical Institute; Zhao Yujun; Li Jia; Wang Zengtao; Zhang Shiyan; Zang Yi; Wang Peipei; Sun Dandan; Zhang Hanyan; (155 pag.)CN110818683; (2020); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider